SV2008002856A - 2-AMINO-7, 8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINA-5-ONAS - Google Patents

2-AMINO-7, 8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINA-5-ONAS

Info

Publication number
SV2008002856A
SV2008002856A SV2008002856A SV2008002856A SV2008002856A SV 2008002856 A SV2008002856 A SV 2008002856A SV 2008002856 A SV2008002856 A SV 2008002856A SV 2008002856 A SV2008002856 A SV 2008002856A SV 2008002856 A SV2008002856 A SV 2008002856A
Authority
SV
El Salvador
Prior art keywords
pirido
dihidro
amino
compounds
pirimidina
Prior art date
Application number
SV2008002856A
Other languages
Spanish (es)
Inventor
Timothy D Machajewski
Cynthia M Shafer
Christopher Mcbride
Mccrea William Antonios
Brandon M Doughan
Barry H Levine
Yi Xia
Maureen Mckenna
Michael X Wang
Kris Mendenhall
Yasheen Zhou
Boaqing Gong
Dan Gu
John Dolan
John Tulinsky
Kristin Brinner
Zhenhai Gao
Daniel Poon
Paul A Barsanti
Xiaodong Lin
Abran Costales
Alice Rico
Nathan Brammeier
Teresa Pick
Paul A Renhowe
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SV2008002856A publication Critical patent/SV2008002856A/en

Links

Abstract

LOS COMPUESTOS REVELADOS SON 2-AMINO-7,8-DIHIDRO-6H-PIRIDO[4,3-D]PIRIMIDINA-5-UNO, SUS ESTEREOISÓMEROS, TAUTOMEROS, SALES ACEPTADAS FARMACÉUTICAMENTE, Y PRO-MEDICAMENTOS DE LO MISMO; LAS COMPOSICIONES QUE INCLUYEN UN PORTADOR FARMACÉUTICAMENTE ACEPTABLE Y UNO O MÁS DE LOS COMPUESTOS 2-AMINO-7,8-DIHIDRO-6H-PIRIDO[4,3-D]PIRIMIDINA-5-UNO, YA SEA SOLOS O EN COMBINACIÓN CON POR LO MENOS UN AGENTE TERAPÉUTICO ADICIONAL. SE REVELAN LOS MÉTODOS DE USO DE LOS COMPUESTOS 2-AMINO-7,8-DIHIDRO-6H-PIRIDO[4,3-D]PIRIMIDINA-5-UNO, YA SEA SOLOS O EN COMBINACIÓN CON POR LO MENOS UN AGENTE TERAPÉUTICO ADICIONAL, EN LA PROFILAXIS TRATAMIENTO DE LAS ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL, CARDIOVASCULARES, AUTOINMUNE, VIRALES, PROLIFERACIÓN CELULARTHE DISCLOSED COMPOUNDS ARE 2-AMINO-7,8-DIHIDRO-6H-PIRIDO [4,3-D] PYRIMIDINE-5-ONE, ITS STEREOISOMMERS, TAUTOMEROS, SALTS PHARMACUTICALLY ACCEPTED, AND PRO-MEDICATIONS OF THE SAME; COMPOSITIONS THAT INCLUDE A PHARMACEUTICALLY ACCEPTABLE CARRIER AND ONE OR MORE OF THE 2-AMINO-7,8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINE-5-ONE COMPOUNDS, ALREADY ALONE OR IN COMBINATION WITH THEM LESS AN ADDITIONAL THERAPEUTIC AGENT. THE METHODS OF USE OF THE 2-AMINO-7,8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINE-5-ONE COMPOUNDS, ALREADY ALONE OR IN COMBINATION WITH AT LEAST AN ADDITIONAL THERAPEUTIC AGENT, ARE DISCLOSED, IN THE PROFILAXIS TREATMENT OF THE DISEASES OF THE CENTRAL NERVOUS SYSTEM, CARDIOVASCULAR, AUTOINMUNE, VIRALS, CELL PROLIFERATION

SV2008002856A 2005-09-30 2008-03-28 2-AMINO-7, 8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINA-5-ONAS SV2008002856A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72279605P 2005-09-30 2005-09-30

Publications (1)

Publication Number Publication Date
SV2008002856A true SV2008002856A (en) 2008-06-30

Family

ID=40059303

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2008002856A SV2008002856A (en) 2005-09-30 2008-03-28 2-AMINO-7, 8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINA-5-ONAS

Country Status (6)

Country Link
CN (1) CN101287734B (en)
AR (1) AR110068A2 (en)
SI (1) SI1928875T1 (en)
SV (1) SV2008002856A (en)
UA (1) UA93522C2 (en)
ZA (1) ZA200803658B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010034670A2 (en) * 2008-09-26 2010-04-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Host cell kinases as targets for antiviral therapies against hcv infection
CN102227221A (en) * 2008-11-28 2011-10-26 诺瓦提斯公司 Pharmaceutical combination containing hsp90 inhibitor and mtor inhibitor
MX2011005671A (en) * 2008-11-28 2011-06-20 Novartis Ag Pharmaceutical combinations comprising a pyrido [4, 3-d] pyrimidine derived hsp90-inhibitor and a her2 inhibitor.
CN107624113B (en) * 2015-05-04 2020-10-23 豪夫迈·罗氏有限公司 Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of HBsAg (HBV surface antigen) and HBV DNA production for the treatment of hepatitis B virus infection
CN109846886A (en) * 2019-03-26 2019-06-07 中国医学科学院基础医学研究所 Purposes of the NVP-HSP990 in the drug of preparation treatment epilepsy
CN114681463B (en) * 2022-04-29 2024-03-15 暨南大学 Application of HSP990 in preparing medicine for preventing and/or treating adenovirus infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6165873A (en) * 1984-09-07 1986-04-04 Mitsui Petrochem Ind Ltd 2-piperazinopyrimidine derivative
US4734418A (en) * 1984-12-14 1988-03-29 Mitsui Petrochemical Industries, Ltd. Quinazoline compounds and antihypertensives
MA21177A1 (en) * 1987-02-11 1988-10-01 May & Baker Ltd CYCLIC DIONES.

Also Published As

Publication number Publication date
SI1928875T1 (en) 2011-10-28
CN101287734B (en) 2011-07-20
UA93522C2 (en) 2011-02-25
CN101287734A (en) 2008-10-15
AR110068A2 (en) 2019-02-20
ZA200803658B (en) 2009-09-30

Similar Documents

Publication Publication Date Title
ECSP088324A (en) 2-AMINO-7,8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINA-5-ONAS
CL2007002062A1 (en) Compounds derived from [1,2,4] triazolo [4,3-a] pyridine, kinase inhibitors; pharmaceutical composition; and its use in the treatment of cancer.
BRPI0510170B8 (en) compound, pharmaceutical composition for the treatment of diseases mediated by the muscarinic acetylcholine receptor and use of the compound
BRPI0616630B8 (en) substituted pyrazole compounds
UY27729A1 (en) QUINASE INHIBITORS.
UY27943A1 (en) COMPOSITIONS AND METHODS TO TREAT CRNCER USING ANTIBODY IMMUNOCATE PLAYS FOR CD44 CYTOTNXICS AND CHEMOTHERAPCUTIC AGENTS
CL2008001540A1 (en) Compounds derived from pyrrolopyridines and pyrazolopyridines; pharmaceutical composition; and use in the treatment of cancer.
CR6577A (en) TRICYCLE POLY INHIBITORS (ADP-RIBOSA) POLYMERASES
CL2009001212A1 (en) Compounds derived from pyrrolo [2,3-d] pyrimidine, kinase inhibitors; pharmaceutical composition comprising them; and its use in the treatment of vascular dementia, CNS disorder, cancer, among others.
CL2008001946A1 (en) Imidazole-derived compounds, ccr2, ccr3, ccr5 receptor antagonists; preparation procedure; and use in the treatment of peripheral vascular diseases.
BRPI0409133A (en) pharmaceutical formulations containing methylnaltrexone
CL2008002139A1 (en) Dimer compounds derived from pyrrolo [2,1c] [1,4] benzodiazepine-5 -one (tomaimycin), a conjugate comprising them; procedure of preparation of conjugates; pharmaceutical composition comprising the compounds or conjugates; and use of compounds and conjugates in the treatment of cancer.
UY29087A1 (en) ADAMANTILE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USE
CL2008003846A1 (en) Use of compounds derived from 1,2,4-triazolo fused with heterocycles, which act as ligands of the androgen receptor (ar); compounds; Preparation process; Pharmaceutical composition and the use of said compounds for the treatment of prostate cancer.
CL2008001813A1 (en) COMPOUNDS DERIVED FROM QUINOLIN-3-CARBONITRILE SUBSTITUTED WITH PIPERAZINE; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS ARTHRITIS, INFLAMMATION, CANCER BETWEEN OTHERS (DIV. SOL. 266-04).
BRPI0412993A (en) akt activity inhibitors
UY27712A1 (en) REPLACED INDAZOLS, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCEDURES
CL2008001626A1 (en) Compounds derived from fused heterocycles, a pharmaceutical agent that comprises them and their use in the prophylaxis and treatment of cancer.
CL2011000116A1 (en) Compounds derived from imidazo [1,2-a] pyridine; preparation procedure; pharmaceutical composition; intermediate compounds; and use in the treatment of cancer.
CL2011000729A1 (en) Compounds derived from methanopyrazolo [3,4-e] [1,3] diazepine; preparation procedure; pharmaceutical composition comprising them; and its use in the treatment of bacterial infections.
CL2007001710A1 (en) Substituted amino-pyrazolopyridine derivatives; Preparation method; pharmaceutical composition; and use in the treatment of diseases such as tumors, rheumatoid arthritis, diseases of deregulated vascular growth, among others.
DE502004002571D1 (en) SUBSTITUTED 3-PYRROLIDIN INDOL DERIVATIVES
SV2008002856A (en) 2-AMINO-7, 8-DIHIDRO-6H-PIRIDO [4,3-D] PIRIMIDINA-5-ONAS
WO2005089294A3 (en) Synthesis of indenoisoquinoliniums and methods of use
MY135829A (en) Analeptic and drug combinations

Legal Events

Date Code Title Description
FG Grant